Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
NCT07138508
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class
Conditions
No Reflow Phenomenon
Anterior STEMI
Interventions
DRUG:
Nicorandil 20mg
Sponsor
Ain Shams University
Collaborators
[object Object]